15 January, 2007 - Ark Therapeutics plc ('Ark') today announces that Frost &
Sullivan has awarded the 2006 European Product Innovation of the Year Award in
the field of Wound Closure to Ark for its efforts in the development and
introduction of the novel Kerraboot(R) product. The dual-action Kerraboot(R)
helps accelerate chronic wound healing, particularly in the lower limbs.
